New Clue to How Cancer Causes Organ Failure
News Jun 19, 2015
Cancer produces a variety of collateral effects in patients beyond the malignancy itself, including threats to distal organ functions. However, the basis for such effects, associated with either primary or metastatic tumors, are generally poorly understood. New findings from a research group at Uppsala University show that the neutrophil, a type of blood cell, plays an important role in this process.
The main function of neutrophils is to protect us from infections, but the presence of a tumor in the body can trick these immune cells to fight an infection that does not exist. This is caused by substances secreted by the tumor that activates neutrophils to form “NETs” (Neutrophil Extracellular Traps). These NETs are formed in a spectacular way when neutrophils externalizes their DNA and together with platelets forms a meshwork that can trap bacteria – an immune reaction that can be crucial during sepsis.
In a newly published article, researchers at the Department of Medical Biochemistry and Microbiology show that NETs accumulate in the peripheral circulation in mice with cancer and causes decreased functionality of blood vessels and inflammation in organs not affected by the actual tumor or metastatic tumor cells.
Since NETs have a high content of extracellular DNA, they can be dissolved by DNase treatment. DNase treatment restored the vascular function in the kidney or heart to levels seen in non-tumor-bearing mice, and also suppressed the inflammatory response.
“Taken together, our findings strongly suggest that NETs mediate the negative collateral effects of tumors on distal organs, but that this condition is reversible. We believe that these findings may add new knowledge to how cancer patients should be treated to avoid organ failure”, says Anna-Karin Olsson, senior lecturer at the Department of Medical Biochemistry and Microbiology, Uppsala University.
Tight junctions are multi-protein complexes that serve as barriers in epithelial tissues such as the skin or lining of the gut. Loss of a specific tight junction barrier protein, claudin 18, occurs in the majority of gastric cancer patients and is correlated with poor prognosis in patients with advanced gastric cancer.READ MORE
Policies, economic systems, and marketing practices that promote the consumption of energy-dense, nutrient-poor food, changing behavioral patterns that couple high total energy intake with insufficient physical activity, and human-built environments that amplify these factors are driving a worldwide rise in excess body weight, according to a new report.READ MORE
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.READ MORE
18th International Conference on Pharmaceutics & Novel Drug Delivery Systems
May 27 - May 28, 2019